Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020

Open access
Ostrom, Quinn T, Price, Mackenzie, Neff, Corey, Cioffi, Gino, Waite, Kristin A, Kruchko, Carol, Barnholtz-Sloan, Jill S · 2023 · Neuro-Oncology

Abstract

The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and the National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains the most up-to-date population-based data on primary brain tumors available and supersedes all previous CBTRUS reports in terms of completeness and accuracy. All rates are age-adjusted using the 2000 US standard population and presented per 100,000 population. The average annual age-adjusted incidence rate (AAAIR) of all malignant and non-malignant brain and other CNS tumors was 24.83 per 100,000 population (malignant AAAIR=6.94 and non-malignant AAAIR=17.88). This overall rate was higher in females compared to males (27.85 versus 21.62 per 100,000) and non-Hispanic persons compared to Hispanic persons (25.24 versus 22.61 per 100,000). Gliomas accounted for 26.3% of all tumors. The most commonly occurring malignant brain and other CNS histopathology was glioblastoma (14.2% of all tumors and 50.9% of all malignant tumors), and the most common predominantly non-malignant histopathology was meningioma (40.8% of all tumors and 56.2% of all non-malignant tumors). Glioblastomas were more common in males, and meningiomas were more common in females. In children and adolescents (ages 0-19 years), the incidence rate of all primary brain and other CNS tumors was 6.13 per 100,000 population. There were 86,030 deaths attributed to malignant brain and other CNS tumors between 2016 and 2020. This represents an average annual mortality rate of 4.42 per 100,000 population and an average of 17,206 deaths per year. The five-year relative survival rate following diagnosis of a malignant brain and other CNS tumor was 35.7%, for a non-malignant brain and other CNS tumor the five-year relative survival rate was 91.8%.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/noad149

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Research works printed but not linked: 14

  1. Louis, 2016, WHO Classification of Tumours of the Central Nervous System
  2. Centers for Disease Control and Prevention National Center for Health Statistics, 2023, National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: U.S. Cancer Statistics Incidence Analytic Database – 2001-2020
  3. Surveillance Epidemiology and End Results (SEER) Program, SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (1969-2020) <Katrina/Rita Population Adjustment>
  4. 2017, International Incidence of Childhood Cancer, Volume III.
  5. Swerdlow, 2007, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition
  6. Kleihues, 2000, Tumours of the nervous system: World Health Organization classification of tumours.
  7. Ferlay, 2019, Histological groups
  8. Central Brain Tumor Registry of the United States SEER*Stat Database, 2023, CDC National Program of Cancer Registries and NCI Surveillance, Epidemiology and End Results Incidence Data, 2022 submission (2000–2020)
  9. 2023, Joinpoint Regression Program, Version 5.0.2.0; Statistical Methodology and Applications Branch, Surveillance Research Program
  10. Neff, 2022, prevEst (version 2.0)
  11. Surveillance Epidemiology and End Results (SEER) Program, 2022, SEER*Stat Database: Incidence - SEER Research Plus Data, 8 Registries, Nov 2021 Sub (1975-2019) - Linked To County Attributes - Total U.S., 1969-2020 Counties
  12. Central Brain Tumor Registry of the United States SEER*Stat Database, 2022, CDC National Program of Cancer Registries and NCI Surveillance, Epidemiology and End Results Incidence Data, 2021 submission (2000–2019)
  13. Bray, 2017, Data Comparability and Quality
  14. Johnson, 2007, The 2007 Multiple Primary and Histology Coding Rules.

Cited by

Metadata

Authors
Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S.
Affiliations
  • Duke University (US)
  • Central Brain Tumor Registry of the United States (US)
  • Central Brain Tumor Registry of the United States , Hinsdale, IL , USA
Corresponding author
Ostrom, Quinn T
Venue
Neuro-Oncology
Published
2023-10-04
Volume
25
Issue
Supplement_4
Pages
iv1-iv99
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
OpenAlex
W4387329303
Cited by
1,294
References
55
Citations by year
2026: 347 · 2025: 440 · 2024: 329 · 2023: 74
FWCI
206.67
Type
journal article
Language
en
Open access
Locations
  • Neuro-Oncology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Centers for Disease Control and Prevention (75D30119C06056)
  • American Brain Tumor Association
  • National Cancer Institute
Topics
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Clinical Neurology › Meningioma and schwannoma management
Keywords
primary brain tumors, central nervous system tumors, incidence, mortality, glioblastoma, meningioma, glioma, pediatric brain tumors, relative survival, sex differences, racial and ethnic disparities, age-standardized rates, cancer registry data
MeSH terms
Adolescent, Brain, Brain Neoplasms, Child, Female, Glioblastoma, Humans, Male, Meningeal Neoplasms, Meningioma, Registries, United States, Incidence, Central Nervous System Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.